


340B Orphan Drug Solutions Revenue
Hospitals and Health Care • 4256 Cypress Glades Lane, Orlando, United States • 1-10 Employees
340B Orphan Drug Solutions revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Hospitals and Health Care industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at 340B Orphan Drug Solutions
Lisa Nezneski
Chief Executive Officer
Company overview
| Headquarters | 4256 Cypress Glades Lane, Orlando, Florida 32824, US |
| Website | |
| NAICS | 62 |
| Employees | 1-10 |
340B Orphan Drug Solutions Email Formats
340B Orphan Drug Solutions uses 1 email format. The most common is {first initial} (e.g., j@340borphandrugsolutions.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@340borphandrugsolutions.com | 100% |
About 340B Orphan Drug Solutions
340B Orphan Drug Solutions specializes in helping rural hospitals, critical access facilities, and healthcare systems maximize their orphan drug savings while ensuring compliance. Our expertise focuses specifically on the complex intersection of 340B programs and orphan drug designations, where we've identified significant opportunities for facilities to enhance their savings and streamline operations. Core Services: - Customized orphan drug NDC lists tailored to your facility's specific needs - Split-billing system integration and optimization - Compliance documentation and audit preparation - Quarterly update management and implementation What Sets Us Apart: We work independently of wholesalers and split-billing software providers, allowing us to focus exclusively on what works best for your facility. Our approach combines decades of healthcare experience with specialized knowledge of 340B orphan drug regulations. Our clients typically experience: - Significant reduction in manual research time - Enhanced compliance confidence - Streamlined operations through automation - Improved capture of eligible savings Whether you're struggling with the quarterly orphan drug updates, preparing for an audit, or simply looking to optimize your current approach, we provide practical solutions that deliver measurable results. Contact us to learn how we can help your facility navigate the complexities of orphan drug management within your 340B program.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
340B Orphan Drug Solutions has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
340B Orphan Drug Solutions has never raised funding before.
Frequently asked questions
4.8
40,000 users



